 |
|
|
| |
Efficacy, Treatment Duration and Safety of boceprevir/peginterferon/ribavirin in Treatment naive Patients With
Hepatitis C Virus Genotype 1 Infection: relationship to baseline fibrosis score
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Lawrence Serfaty,1 John Vierling,2 Fred Poordad,3 Steven Flamm,4 Bruce Bacon,5 Weiping Deng,6 Kenneth Koury,6 Karin Hagen,6 Katia Alves,6 Janice Wahl6
1Hopital Saint Antoine, APHP and INSERM UMR_938, Universite Pierre & Marie Curie, Paris, France; 2Baylor College of Medicine, St Lukes Episcopal Hospital, Houston, TX; 3The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX;
4Northwestern Feinberg School of Medicine, Chicago, IL; 5Saint Louis University School of Medicine, St Louis, MO; 6Merck & Co., Inc, Whitehouse Station, NJ USA
|
| |
|
|
|
|
|
